ImmunityBio, Inc. Patent Application Trends in 2024

ImmunityBio, Inc. patent applications in 2024

Top 10 Technology Areas

• C12N5/0646 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 6 patents
  • Example: 20240228964. Highly Potent M-CENK Cells And Methods simplified abstract (ImmunityBio, Inc.)
• A61K35/17 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 6 patents
  • Example: 20240228964. Highly Potent M-CENK Cells And Methods simplified abstract (ImmunityBio, Inc.)
• A61P35/00 (Antineoplastic agents)
  • Count: 5 patents
  • Example: 20240228964. Highly Potent M-CENK Cells And Methods simplified abstract (ImmunityBio, Inc.)
• A61K39/215 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 3 patents
  • Example: 20240226282. Nant COVID Vaccine Cross Reactivity simplified abstract (ImmunityBio, Inc.)
• A61P31/14 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
  • Count: 3 patents
  • Example: 20240226282. Nant COVID Vaccine Cross Reactivity simplified abstract (ImmunityBio, Inc.)
• C12N2501/2315 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 3 patents
  • Example: 20240228964. Highly Potent M-CENK Cells And Methods simplified abstract (ImmunityBio, Inc.)
• C12N2510/00 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 3 patents
  • Example: 20240010979. MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC simplified abstract (ImmunityBio, Inc.)
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca)
  • Count: 3 patents
  • Example: 20240156934. Compositions And Methods Of MAIT Cell Activation simplified abstract (ImmunityBio, Inc.)
• C07K2317/622 (PEPTIDES (peptides in foodstuffs)
  • Count: 3 patents
  • Example: 20240002802. MODIFIED NK-92 CELLS FOR TREATING CANCER simplified abstract (ImmunityBio, Inc.)
• C07K2319/03 (PEPTIDES (peptides in foodstuffs)
  • Count: 3 patents
  • Example: 20240002802. MODIFIED NK-92 CELLS FOR TREATING CANCER simplified abstract (ImmunityBio, Inc.)

Emerging Technology Areas

• A61K2239/22 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240042023. Fc-Receptor CAR Constructs and Cells simplified abstract (ImmunityBio, Inc.)
• A61K2239/13 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240042023. Fc-Receptor CAR Constructs and Cells simplified abstract (ImmunityBio, Inc.)
• A61K2239/17 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240042023. Fc-Receptor CAR Constructs and Cells simplified abstract (ImmunityBio, Inc.)
• A61K39/464411 ({Cellular immunotherapy})
  • Count: 1 patents
  • Example: 20240042023. Fc-Receptor CAR Constructs and Cells simplified abstract (ImmunityBio, Inc.)
• A61K39/4631 ({Cellular immunotherapy})
  • Count: 1 patents
  • Example: 20240042023. Fc-Receptor CAR Constructs and Cells simplified abstract (ImmunityBio, Inc.)
• C07K16/283 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240042023. Fc-Receptor CAR Constructs and Cells simplified abstract (ImmunityBio, Inc.)
• C07K14/7051 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240042023. Fc-Receptor CAR Constructs and Cells simplified abstract (ImmunityBio, Inc.)
• A61K39/4613 ({Cellular immunotherapy})
  • Count: 1 patents
  • Example: 20240042023. Fc-Receptor CAR Constructs and Cells simplified abstract (ImmunityBio, Inc.)
• C07K2317/53 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240238623. Chimeric Antigen Receptor-Modified NK-92 Cells simplified abstract (ImmunityBio, Inc.)
• C07K16/32 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240238623. Chimeric Antigen Receptor-Modified NK-92 Cells simplified abstract (ImmunityBio, Inc.)

Top Inventors

Error creating thumbnail: File missing

• Patrick Soon-Shiong of Culver City CA (US) (7 patents)
• Manju Saxena of Culver City CA (US) (2 patents)
• Syed Raza Ali of Culver City CA (US) (2 patents)
• Greg Anderson of Culver City CA (US) (2 patents)
• Laurent H. Boissel of Culver City CA (US) (2 patents)
• Hans G. Klingemann of Culver City CA (US) (2 patents)
• Hans Klingemann of Boston MA (US) (1 patent)
• Laurent Boissel of Boston MA (US) (1 patent)
• Patrick Soon-Shiong of Los Angeles CA (US) (1 patent)
• Rohit DUGGAL of San Diego CA (US) (1 patent)

Patent Categories

Error creating thumbnail: File missing

Geographical Distribution of Inventors

Error creating thumbnail: File missing

Geographical Distribution of US Inventors